ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Sees Significant Decline in Short Interest

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 5,804 shares, a drop of 82.5% from the April 30th total of 33,182 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 29,325 shares, the short-interest ratio is presently 0.2 days.

ALPS Group Inc Ordinary Share Trading Down 3.6%

Shares of NASDAQ ALPS traded down $0.03 during midday trading on Friday, reaching $0.74. The company’s stock had a trading volume of 1,140 shares, compared to its average volume of 35,982. The company has a market cap of $123.47 million, a price-to-earnings ratio of 2.25 and a beta of -0.12. ALPS Group Inc Ordinary Share has a fifty-two week low of $0.56 and a fifty-two week high of $15.00.

Analysts Set New Price Targets

Separately, Weiss Ratings initiated coverage on shares of ALPS Group Inc Ordinary Share in a research report on Wednesday, April 8th. They issued a “sell (e+)” rating for the company. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

About ALPS Group Inc Ordinary Share

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.